Immunization with clinical HIV-1 env proteins induces broad antibody dependent cellular cytotoxicity-mediating antibodies in a rabbit vaccination model

NGIN Consortium

Research output: Contribution to journalA1: Web of Science-articlepeer-review

Abstract

The induction of both neutralizing antibodies and non-neutralizing antibodies with effector functions, for example, antibody-dependent cellular cytotoxicity (ADCC), is desired in the search for effective vaccines against HIV-1. In the pursuit of novel immunogens capable of inducing an efficient antibody response, rabbits were immunized with selected antigens using different prime-boost strategies. We immunized 35 different groups of rabbits with Env antigens from clinical HIV-1 subtypes A and B, including immunization with DNA alone, protein alone, and DNA prime with protein boost. The rabbit sera were screened for ADCC activity using a GranToxiLux-based assay with human peripheral blood mononuclear cells as effector cells and CEM.NKRCCR5 cells coated with HIV-1 envelope as target cells. The groups with the highest ADCC activity were further characterized for cross-reactivity between HIV-1 subtypes. The immunogen inducing the most potent and broadest ADCC response was a trimeric gp140. The ADCC activity was highest against the HIV-1 subtype corresponding to the immunogen. The ADCC activity did not necessarily reflect neutralizing activity in the pseudovirus-TZMbl assay, but there was an overall correlation between the two antiviral activities. We present a rabbit vaccination model and an assay suitable for screening HIV-1 vaccine candidates for the induction of ADCC-mediating antibodies in addition to neutralizing antibodies. The antigens and/or immunization strategies capable of inducing antibodies with ADCC activity did not necessarily induce neutralizing activity and vice versa. Nevertheless, we identified vaccine candidates that were able to concurrently induce both types of responses and that had ADCC activity that was cross-reactive between different subtypes. When searching for an effective vaccine candidate, it is important to evaluate the antibody response using a model and an assay measuring the desired function.

Original languageEnglish
JournalAIDS Research and Human Retroviruses
Volume34
Issue number2
Pages (from-to)206-217
Number of pages12
ISSN0889-2229
DOIs
Publication statusPublished - 2018

Keywords

  • ADCC
  • vaccine development
  • neutralizing antibody
  • antibody mediated immunity
  • NEUTRALIZING ANTIBODY
  • DISEASE PROGRESSION
  • ANTIRETROVIRAL THERAPY
  • HUMORAL IMMUNITY
  • RESPONSES
  • MACAQUES
  • VACCINES
  • TYPE-1
  • CELLS
  • NORMALIZATION

Fingerprint

Dive into the research topics of 'Immunization with clinical HIV-1 env proteins induces broad antibody dependent cellular cytotoxicity-mediating antibodies in a rabbit vaccination model'. Together they form a unique fingerprint.

Cite this